News Releases

Webcast Johnson & Johnson Third Quarter 2014 Earnings Meeting and Webcast
October 14, 2014
8:30 AM ET

All Releases
View Summary Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production
Oct 22, 2014
PDF 12.0 KB Add to Briefcase
View Summary IMBRUVICA® (ibrutinib) Supplemental New Drug Application Submitted to the U.S. FDA for Waldenström's macroglobulinemia
Oct 20, 2014
PDF 67.5 KB Add to Briefcase
View Summary European Commission Approves IMBRUVICATM in Two Forms of Blood Cancer
Oct 17, 2014
PDF 69.9 KB Add to Briefcase
View Summary Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2014
Oct 16, 2014
PDF 5.6 KB Add to Briefcase
View Summary Johnson & Johnson Reports 2014 Third-Quarter Results:
Oct 14, 2014
PDF 65.1 KB Add to Briefcase
View Summary Bristol-Myers Squibb, Pharmacyclics and Janssen Announce Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and IMBRUVICA®(ibrutinib) in Non-Hodgkin Lymphoma
Oct 13, 2014
PDF 22.2 KB Add to Briefcase
View Summary Janssen Demonstrates Continued Commitment to Combating Hepatitis C in European Patients with Data Presented at Viral Hepatitis Congress
Oct 10, 2014
PDF 49.0 KB Add to Briefcase
View Summary Janssen Submits Application Seeking Approval Of STELARA® In European Union For Pediatric Plaque Psoriasis
Oct 10, 2014
PDF 16.9 KB Add to Briefcase
View Summary New Findings From The Psoriasis Longitudinal Assessment And Registry (PSOLAR)
Oct 9, 2014
PDF 16.3 KB Add to Briefcase
View Summary Johnson & Johnson Announces Agreement To Acquire Alios BioPharma
Sep 30, 2014
PDF 9.1 KB Add to Briefcase
View Summary CHMP Announces Positive Opinion For REZOLSTA, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat
Sep 29, 2014
PDF 12.6 KB Add to Briefcase
View Summary ZYTIGA® Plus Prednisone Demonstrates Statistically Significant Overall Survival After 49-Month Follow-Up Analysis in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer
Sep 28, 2014
PDF 17.7 KB Add to Briefcase
View Summary Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
Sep 23, 2014
PDF 7.3 KB Add to Briefcase
View Summary FDA Approves New Styles Of The MENTOR® MemoryShape® Silicone Breast Implant
Sep 15, 2014
PDF 14.6 KB Add to Briefcase
View Summary Cordis Corporation Launches INCRAFT® AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)
Sep 10, 2014
PDF 12.8 KB Add to Briefcase
View Summary Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
Sep 4, 2014
PDF 13.7 KB Add to Briefcase
View Summary Johnson & Johnson to Participate in 2014 Morgan Stanley Health Care Conference
Sep 3, 2014
PDF 5.7 KB Add to Briefcase
View Summary New Data Show Once-Daily XARELTO® May Be an Alternative to Vitamin K Antagonists in Treating Atrial Fibrillation Patients Undergoing Elective Cardioversion
Sep 2, 2014
PDF 32.2 KB Add to Briefcase
View Summary Janssen Expands EXPLORER Global Cardiovascular Research Program to Evaluate the Role of XARELTO® in Addressing Critical Medical Needs
Aug 29, 2014
PDF 24.2 KB Add to Briefcase
View Summary Janssen Affiliate Cilag GmbH International Acquires Covagen AG
Aug 25, 2014
PDF 11.5 KB Add to Briefcase

= add release to Briefcase